COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 1535: Articles 15341-15350  | Next

Adenovirus transduction to express human ACE2 causes obesity-specific morbidity in mice, impeding studies on the effect of host nutritional status on SARS-CoV-2 pathogenesis.
Rai, P., Chuong, C., LeRoith, T., Smyth, J. W., Duggal, N. K., Weger-Lucarelli, J., Panov, J., Levi, M., Hall, K. K.
10.1101/2021.05.26.445786 — Posted: 2021-05-26
A modular molecular framework for quickly estimating the binding affinity of the spike protein of SARS-CoV-2 variants for ACE2, in presence of mutations at the spike receptor binding domain.
Tragni, V., Preziusi, F., Laera, L., Onofrio, A., Todisco, S., Volpicella, M., De Grassi, A., Pierri, C. L.
10.1101/2021.05.26.445422 — Posted: 2021-05-26
Variable Induction of Pro-inflammatory Cytokines by Commercial SARS CoV-2 Spike Protein Reagents: Potential Impacts of LPS on In Vitro Modeling and Pathogenic Mechanisms In Vivo
Ouyang, W., Xie, T., Fang, H., Gao, C., Stantchev, T., Clouse, K. A., Yuan, K., Ju, T., Frucht, D. M.
10.1101/2021.05.26.445843 — Posted: 2021-05-26
SARS-CoV-2 Nsp14 activates NF-κB signaling and induces IL-8 upregulation
Li, T.-W., Kenney, A. D., Liu, H., Fiches, G. N., Zhou, D., Biswas, A., Que, J., Santoso, N., Yount, J. S., Zhu, J.
10.1101/2021.05.26.445787 — Posted: 2021-05-26
Evidence of neutralizing antibodies against SARS-CoV-2 in domestic cats living with owners with a history of COVID-19 in Lima, Peru
Jara, L. M., Ferradas, C., Schiaffino, F., Sanchez-Carrion, C., Martinez, A., Ulloa, A., Isasi-Rivas, G., Montalvan, A., Sarmiento, L. G., Fernandez Diaz, M. C., Zimic, M.
10.1101/2021.05.26.445880 — Posted: 2021-05-26
Multi-level multi-state modelling applied to hospital admission in mexican patients with COVID-19
Diaz-Martinez, J. P., Orozco-Becerril, K. J., Gallegos-Herrada, M. A., Fuentes-Garcia, R., Gutierrez-Garcia, M. A., Espin-Garcia, O.
10.1101/2021.05.24.21257752 — Posted: 2021-05-26
Frailty variation models for susceptibility and exposure to SARS-CoV-2
Gomes, M. G. M., Ferreira, M. U., Chikina, M., Pegden, W., Aguas, R.
10.1101/2021.05.25.21257766 — Posted: 2021-05-26
Effective prophylaxis of COVID-19 in rhesus macaques using a combination of two parentally-administered SARS-CoV-2 neutralizing antibodies
Beddingfield, B. J., Maness, N. J., Fears, A. C., Rappaport, J., Aye, P. P., Russell-Lodrigue, K. E., Doyle-Meyers, L. A., Blair, R. V., Carias, A. M., Redondo, R. L., Madden, P. J., Gao, H., Montefiori, D., Hope, T. J., ROY, C. J.
10.1101/2021.05.26.445878 — Posted: 2021-05-26
Impaired function and delayed regeneration of dendritic cells in COVID-19
Winheim, E., Rinke, L., Lutz, K., Reischer, A., Leutbecher, A., Wolfram, L., Rausch, L., Kranich, J., Wratil, P. R., Huber, J., Baumjohann, D., Rothenfusser, S., Hellmuth, J., Scherer, C., Muenchhoff, M., von Bergwelt-Baildon, M., Stark, K., Straub, T., Brocker, T., Keppler, O. T., Subklewe, M., Krug, A. B.
10.1101/2021.05.26.445809 — Posted: 2021-05-26
Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence
Talla, A., Vasaikar, S. V., Lemos, M. P., Moodie, Z., Pebworth, M.-P. L., Henderson, K. E., Cohen, K. W., Czartoski, J. L., Lai, L., Suthar, M. S., Heubeck, A. T., Genge, P. C., Roll, C. M., Weiss, M., Reading, J., Kondza, N., MacMillan, H., Fong, O. C., Thomson, Z. J., Graybuck, L. T., Newell, E. W., Coffey, E. M., Meijer, P., Becker, L. A., De Rosa, S. C., Torgerson, T. R., Skene, P. J., Li, X., Szeto, G. L., McElrath, M. J., Bumol, T. F.
10.1101/2021.05.26.442666 — Posted: 2021-05-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).